Neutralizing tumor-promoting chronic inflammation: a magic bullet?

Neutralizing tumor-promoting chronic inflammation: a magic bullet?
复制标题

DOI:
10.1126/science.1232227
复制
发表时间:
2013-01-18
期刊:
Science (New York, N.Y.)
影响因子:
--
通讯作者:
Palucka AK
Palucka AK
中科院分区:
其他
文献类型:
--
作者:
Coussens LM;Zitvogel L;Palucka AK

文献摘要

参考文献

被引文献

相似文献

在过去的十年中,癌症诊断和治疗取得了重大进展。除了化学治疗剂和放射治疗之外,方法现在包括靶向与癌细胞中的遗传畸变相关的癌细胞内在介体,以及癌细胞外在途径,特别是调节实体瘤的血管编程的那些。最近,免疫治疗已经进入临床,主要是基于认识到几种免疫细胞亚群,当慢性激活时,促进肿瘤发展。在这里,我们讨论了临床和实验研究,描绘了免疫细胞亚群在癌症相关炎症中的促肿瘤作用。其中一些细胞可以被靶向重新编程其功能,导致癌症促进慢性炎症的消退或至少中和,从而促进癌症排斥。
There have been substantial advances in cancer diagnostics and therapies in the past decade. Besides chemotherapeutic agents and radiation therapy, approaches now include targeting cancer cell–intrinsic mediators linked to genetic aberrations in cancer cells, in addition to cancer cell–extrinsic pathways, especially those regulating vascular programming of solid tumors. More recently, immunotherapeutics have entered the clinic largely on the basis of the recognition that several immune cell subsets, when chronically activated, foster tumor development. Here, we discuss clinical and experimental studies delineating protumorigenic roles for immune cell subsets that are players in cancer-associated inflammation. Some of these cells can be targeted to reprogram their function, leading to resolution, or at least neutralization, of cancer-promoting chronic inflammation, thereby facilitating cancer rejection.
DOI: 10.1186/1479-5876-10-205
发表时间: 2012-10-03
影响因子: 7.4
作者:
Galon J;Pagès F;Marincola FM;Angell HK;Thurin M;Lugli A;Zlobec I;Berger A;Bifulco C;Botti G;Tatangelo F;Britten CM;Kreiter S;Chouchane L;Delrio P;Arndt H;Asslaber M;Maio M;Masucci GV;Mihm M;Vidal-Vanaclocha F;Allison JP;Gnjatic S;Hakansson L;Huber C;Singh-Jasuja H;Ottensmeier C;Zwierzina H;Laghi L;Grizzi F;Ohashi PS;Shaw PA;Clarke BA;Wouters BG;Kawakami Y;Hazama S;Okuno K;Wang E;O'Donnell-Tormey J;Lagorce C;Pawelec G;Nishimura MI;Hawkins R;Lapointe R;Lundqvist A;Khleif SN;Ogino S;Gibbs P;Waring P;Sato N;Torigoe T;Itoh K;Patel PS;Shukla SN;Palmqvist R;Nagtegaal ID;Wang Y;D'Arrigo C;Kopetz S;Sinicrope FA;Trinchieri G;Gajewski TF;Ascierto PA;Fox BA
通讯作者: Fox BA
DOI: 10.1158/1078-0432.ccr-08-1283
发表时间: 2009-02-01
期刊: Clinical cancer research : an official journal of the American Association for Cancer Research
影响因子: --
作者:
Beck AH;Espinosa I;Edris B;Li R;Montgomery K;Zhu S;Varma S;Marinelli RJ;van de Rijn M;West RB
通讯作者: West RB
DOI: 10.1016/j.molmed.2010.03.003
发表时间: 2010-05
影响因子: 13.6
作者:
Freund A;Orjalo AV;Desprez PY;Campisi J
通讯作者: Campisi J
DOI: 10.1038/nature08782
发表时间: 2010-03-11
期刊: Nature
影响因子: 64.8
作者:
通讯作者: --
DOI: 10.1016/j.ccr.2012.08.017
发表时间: 2012-10-16
期刊: CANCER CELL
影响因子: 50.3
作者:
Demehri, Shadmehr;Turkoz, Ahu;Kopan, Raphael
通讯作者: Kopan, Raphael